お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
942630

ゲノム編集・ゲノムエンジニアリングの世界市場 (~2025年):CRISPR・TALEN・ZFN・アンチセンス

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User & Region-Global Forecast to 2025

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 148 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
ゲノム編集・ゲノムエンジニアリングの世界市場 (~2025年):CRISPR・TALEN・ZFN・アンチセンス
出版日: 2020年06月09日
発行: MarketsandMarkets
ページ情報: 英文 148 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のゲノム編集・ゲノムエンジニアリングの市場は予測期間中17.0%のCAGRで推移し、2020年の51億米ドルから、2025年には112億米ドルの規模に成長すると予測されています。政府資金の投入拡大、ゲノミクスプロジェクト件数の増加、感染症および癌の有病率の高さ、技術的進歩、GM作物の生産量の増加、ゲノミクスの応用分野の拡大などの要因が同市場の成長を推進しています。しかし一方で、ゲノム機器の高コスト性が市場のさらなる成長の妨げとなっています。技術別で見ると、技術の扱いやすさやマルチプレックス機能から、CRISPR部門が2019年の最大のシェアを獲得しました。またエンドユーザー別では、製薬会社が同年、最大のシェアを獲得しました。同部門の成長は、感染症や癌の有病率の増加から、医薬品開発が活発化していることに起因しています。さらに地域別では、アジア太平洋地域が予測期間中、最大のCAGRを示すと予測されています。同地域の製薬・バイオ医薬品業界の急速な成長、ゲノムプロジェクトの増加、遺伝的に多様な人口の存在などの要因が、同地域の高い成長率を支えています。

当レポートでは、世界のゲノム編集・ゲノムエンジニアリングの市場を調査し、市場の定義と概要、バリューチェーン、市場成長への各種影響因子の分析、市場規模の推移・予測、技術・用途・製品&サービス区分・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業プロファイルなどをまとめています。

942630_4.3 GENOME EDITING-GENOME ENGINEERING MARKET,BY APPLICATION (USD MILLION)_FIGURE 11

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 市場機会
    • 課題
  • バリューチェーン分析
  • COVID-19の影響

第6章 市場分析・予測:技術別

  • イントロダクション
  • CRISPR
  • TALEN
  • ZFN
  • アンチセンス
  • その他

第7章 市場分析・予測:用途別

  • イントロダクション
  • 細胞株エンジニアリング
  • 遺伝子工学
    • 動物遺伝子工学
    • 植物遺伝子工学
  • 診断
  • 薬物の発見・開発
  • その他

第8章 市場分析・予測:製品・サービス別

  • イントロダクション
  • 試薬・消耗品
  • ソフトウェア・システム
  • サービス

第9章 市場分析・予測:エンドユーザー別

  • イントロダクション
  • 製薬会社
  • バイオテクノロジー企業
  • 学術・政府研究機関

第10章 市場分析・予測:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • フランス
    • ドイツ
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第11章 競合情勢

  • イントロダクション
  • 市場ランキング分析
  • 市場評価フレームワーク
  • 競合リーダーシップマッピング
  • 競合シナリオ

第12章 企業プロファイル

  • THERMO FISHER SCIENTIFIC
  • MERCK
  • HORIZON DISCOVERY
  • GENSCRIPT
  • SANGAMO THERAPEUTICS
  • LONZA
  • EDITAS MEDICINE
  • CRISPR THERAPEUTICS
  • EUROFINS SCIENTIFIC
  • PRECISION BIOSCIENCES
  • OXFORD GENETICS
  • INTELLIA THERAPEUTICS
  • SYNTHEGO
  • VIGENE BIOSCIENCES
  • EPIGENIE
  • INTEGRATED DNA TECHNOLOGIES
  • NEW ENGLAND BIOLABS
  • ORIGENE TECHNOLOGIES
  • TRANSPOSAGEN BIOPHARMACEUTICALS
  • CREATIVE BIOGENE

第13章 付録

図表

LIST OF TABLES

  • TABLE 1 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 2 GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 3 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 4 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 5 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 6 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 7 GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 8 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 9 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 10 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 11 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 12 GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 13 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 14 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 15 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 16 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 17 GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 18 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 19 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 20 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 21 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 22 GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 23 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)  
  • TABLE 24 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 25 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 26 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 27 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 28 GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 29 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 30 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 31 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 32 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 33 GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 34 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 35 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 36 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 37 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 38 GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 39 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 40 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 41 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 42 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 43 GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 44 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 45 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 46 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 47 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 48 GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)  
  • TABLE 49 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 50 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 51 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 52 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 53 GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 54 GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 55 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 56 EUROPE: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 57 APAC: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 58 ROW: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 59 GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 60 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 61 EUROPE: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 62 APAC: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 63 ROW: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 64 GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 65 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 66 EUROPE: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 67 APAC: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 68 ROW: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 69 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 70 GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 71 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 72 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 73 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)  
  • TABLE 74 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 75 GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 76 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 77 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 78 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 79 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 80 GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 81 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 82 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 83 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 84 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 85 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 86 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 87 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 88 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 89 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 90 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 91 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 92 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 93 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 94 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 95 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 96 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 97 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)  
  • TABLE 98 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 99 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 100 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 101 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 102 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 103 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 104 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 105 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 106 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 107 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 108 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 109 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 110 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 111 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 112 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 113 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 114 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2017-2025 (USD MILLION)
  • TABLE 115 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 116 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 117 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 118 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 119 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 120 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 121 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 122 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)  
  • TABLE 123 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 124 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 125 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 126 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 127 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 128 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 129 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 130 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 131 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 132 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 133 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 134 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 135 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 136 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 137 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 138 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 139 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 140 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 141 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 142 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 143 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 144 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 145 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 146 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 147 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)  
  • TABLE 148 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 149 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 150 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 151 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 152 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • TABLE 153 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 154 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCH WAS THE MAJOR STRATEGY ADOPTED BY MAJOR PLAYERS IN 2017

LIST OF FIGURES

  • FIGURE 1 BREAKDOWN OF PRIMARIES
  • FIGURE 2 DATA TRIANGULATION METHODOLOGY
  • FIGURE 3 GENOME EDITING/GENOME ENGINEERING MARKET SIZE (USD BILLION)
  • FIGURE 4 GENOME EDITING/GENOME ENGINEERING MARKET CAGR PROJECTIONS FROM AN ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
  • FIGURE 5 GENOME EDITING/GENOME ENGINEERING MARKET SHARE, BY APPLICATION, 2019
  • FIGURE 6 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2020-2025
  • FIGURE 7 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
  • FIGURE 8 GEOGRAPHICAL SNAPSHOT OF THE GENOME EDITING/GENOME ENGINEERING MARKET
  • FIGURE 9 RISING R&D FUNDING AND HIGH PREVALENCE OF INFECTIOUS DISEASES ARE THE PRIMARY GROWTH DRIVERS FOR THE MARKET
  • FIGURE 10 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET
  • FIGURE 11 CELL LINE ENGINEERING SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019
  • FIGURE 12 PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019
  • FIGURE 13 VALUE CHAIN ANALYSIS OF THE GENOME EDITING/GENOME ENGINEERING MARKET: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
  • FIGURE 14 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2020 VS. 2025
  • FIGURE 15 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET SNAPSHOT
  • FIGURE 16 APAC: GENOME EDITING/GENOME ENGINEERING MARKET SNAPSHOT
  • FIGURE 17 COMPANY RANKING IN THE GENOME EDITING/GENOME ENGINEERING MARKET, 2019
  • FIGURE 18 GENOME EDITING/GENOME ENGINEERING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
  • FIGURE 19 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
  • FIGURE 20 MERCK: COMPANY SNAPSHOT (2019)
  • FIGURE 21 HORIZON DISCOVERY: COMPANY SNAPSHOT (2018)
  • FIGURE 22 GENSCRIPT: COMPANY SNAPSHOT (2019)
  • FIGURE 23 SANGAMO THERAPEUTICS: COMPANY OVERVIEW (2019)
  • FIGURE 24 LONZA: COMPANY SNAPSHOT (2019)
  • FIGURE 25 EDITAS MEDICINE: COMPANY SNAPSHOT (2018)
  • FIGURE 26 CRISPR THERAPEUTICS: COMPANY SNAPSHOT (2019)
  • FIGURE 27 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
  • FIGURE 28 PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2019)
目次
Product Code: BT 3380

"Rising government funding and increase in the number of genomic projects, especially in the area of rare diseases, and a growing application horizon are all expected to drive the growth of the genome editing/genome engineering market."

The global genome editing/genome engineering market is projected to reach USD 11.2 billion in 2025 from USD 5.1 billion in 2020, at a CAGR of 17.0 % during the forecast period. Market growth is largely driven by factors such as the rise in government funding, growth in the number of genomics projects, high prevalence of infectious diseases & cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. However, the high cost of genomic equipment will restrain the growth of this market.

"CRISPR commanded the largest share of the market in 2019."

Based on technology, the market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies. CRISPR accounted for the largest share of the genome editing/genome engineering market in 2019. The large share of this segment can be attributed to the ease of use associated with the CRISPR technology and its ability to multiplex.

"Pharmaceutical companies commanded the largest share of the genome editing/genome engineering market in 2019."

By end user, the genome editing/genome engineering market is segmented into pharmaceutical companies, biotechnology companies, and academic & government research institutes. The pharmaceutical companies segment accounted for the largest share of the market. The pharmaceutical companies segment accounted for the largest share of the genome editing/genome engineering market in 2019. This is due to the increasing prevalence of infectious diseases and cancer, which is driving research in the pharma sector for drug development.

"The Asia Pacific region will register the highest growth in the global genome editing/genome engineering market during the forecast period."

The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the rapid growth in the pharmaceutical and biopharmaceutical industry, the rising number of genomic projects, and the presence of a genetically diverse population have supported the region's high growth rate.

In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other directors, and executives from various key organizations operating in the genome editing/genome engineering market.

  • By Respondent Type: Supply Side (80%) and Demand Side (20%)
  • By Designation: D-level (55%), C-level (20%), and Others (25%)
  • By Region: North America (50%), Europe (20%), Asia Pacific (20%), and RoW (10%)

The major companies in the genome editing/genome engineering market include Thermo Fisher Scientific (US), Merck (Germany), Horizon Discovery Limited (UK), Lonza (Switzerland), GenScript (US), Eurofins Scientific (Luxembourg), and Sangamo Therapeutics (US).

The study includes an in-depth competitive analysis of these key players in the genome editing/genome engineering market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the genome editing/genome engineering market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, such as products, technology, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall genome editing/genome engineering market and its subsegments. This report will help stakeholders to understand the competitive landscape, gain insights to better position their businesses, and plan suitable go-to-market strategies. The report will also help stakeholders to understand the pulse of the market and provide information on the key market drivers, restraints, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
  • 2.2 MARKET DATA ESTIMATION & TRIANGULATION
    • 2.2.1 DATA TRIANGULATION
  • 2.3 MARKET ESTIMATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 GENOME EDITING/GENOME ENGINEERING MARKET OVERVIEW
  • 4.2 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY SOLUTION AND COUNTRY (2019)
  • 4.3 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION (USD MILLION)
  • 4.4 GENOME EDITING/GENOME ENGINEERING MARKET SHARE, BY END USER, 2019

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS: DRIVERS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising government funding and growth in the number of genomics projects
      • 5.2.1.2 Expanding application areas of genomics
      • 5.2.1.3 Introduction of CRISPR-Cas9
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Extensive use of genome editing in personalized medicine
      • 5.2.2.2 Emerging markets
    • 5.2.3 CHALLENGES
      • 5.2.3.1 High equipment costs
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 IMPACT OF COVID-19 OUTBREAK ON THE GENOME EDITING/GENOME ENGINEERING MARKET

6 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY

  • 6.1 INTRODUCTION
  • 6.2 CRISPR
    • 6.2.1 EASE OF USE GIVES CRISPR AN ADVANTAGE OVER OTHER TECHNOLOGIES
  • 6.3 TALEN
    • 6.3.1 QUICK MODIFICATIONS IN THE GENOME SEQUENCE ARE POSSIBLE WITH TALEN
  • 6.4 ZFN
    • 6.4.1 EUKARYOTE CELL STUDIES DONE BY ZFN TO DRIVE MARKET GROWTH
  • 6.5 ANTISENSE
    • 6.5.1 INCREASED APPLICATION IN ENGINEERING HUMAN CELLS FOR DISEASE STUDY TO DRIVE MARKET GROWTH
  • 6.6 OTHER TECHNOLOGIES

7 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 CELL LINE ENGINEERING
    • 7.2.1 INCREASING RESEARCH APPLICATIONS OF CELL LINE ENGINEERING TO PROMOTE MARKET GROWTH
  • 7.3 GENETIC ENGINEERING
    • 7.3.1 ANIMAL GENETIC ENGINEERING
      • 7.3.1.1 Use of animal simulation models in research to increase the demand for genome editing
    • 7.3.2 PLANT GENETIC ENGINEERING
      • 7.3.2.1 Growing attention on GM crops will drive demand for genetic engineering in crops
  • 7.4 DIAGNOSTIC APPLICATIONS
    • 7.4.1 GROWING APPLICATION HORIZON IN DIAGNOSTICS WILL FAVOR MARKET GROWTH
  • 7.5 DRUG DISCOVERY & DEVELOPMENT
    • 7.5.1 GROWING RESEARCH AND APPLICATIONS IN DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET GROWTH
  • 7.6 OTHER APPLICATIONS

8 GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE

  • 8.1 INTRODUCTION
  • 8.2 REAGENTS & CONSUMABLES
    • 8.2.1 REAGENTS & CONSUMABLES HOLD THE LARGEST MARKET SHARE
  • 8.3 SOFTWARE & SYSTEMS
    • 8.3.1 RISING APPLICATION OF GENOME EDITING/SEQUENCING TO INCREASE THE DEMAND FOR SYSTEMS AND SOFTWARE
  • 8.4 SERVICES
    • 8.4.1 WIDE APPLICATION OF SERVICES TO INCREASE MARKET GROWTH

9 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 PHARMACEUTICAL COMPANIES
    • 9.2.1 CRISPR TECHNOLOGIES ARE USED BY PHARMACEUTICAL COMPANIES FOR APPLICATIONS IN GENE THERAPIES
  • 9.3 BIOTECHNOLOGY COMPANIES
    • 9.3.1 INCREASING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR MARKET PRODUCTS IN BIOTECH COMPANIES
  • 9.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
    • 9.4.1 TREND OF COLLABORATIVE RESEARCH WILL SUPPORT MARKET GROWTH

10 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 US dominates the North American market
    • 10.2.2 CANADA
      • 10.2.2.1 Availability of research funding in Canada drives the market growth
  • 10.3 EUROPE
    • 10.3.1 UK
      • 10.3.1.1 UK is the largest market for genome engineering in Europe
    • 10.3.2 FRANCE
      • 10.3.2.1 Government funding for genomics and rising investments into research show potential for market growth
    • 10.3.3 GERMANY
      • 10.3.3.1 Strong academic base and rising awareness are key growth drivers in Germany
    • 10.3.4 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 CHINA
      • 10.4.1.1 China to hold the largest share of the market in the Asia Pacific
    • 10.4.2 JAPAN
      • 10.4.2.1 Focus on cancer research showcases favorable scenario for the market in Japan
    • 10.4.3 INDIA
      • 10.4.3.1 Growing number of startups and government support indicates growth potential
    • 10.4.4 REST OF ASIA PACIFIC
  • 10.5 ROW
    • 10.5.1 LATAM
      • 10.5.1.1 Latin America is an attractive market for genomics in the RoW
    • 10.5.2 MIDDLE EAST & AFRICA
      • 10.5.2.1 Rising prevalence of genomic disorders in the Middle East and the adoption of genetic testing are driving market growth

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 MARKET RANKING ANALYSIS
  • 11.3 MARKET EVALUATION FRAMEWORK
  • 11.4 COMPETITIVE LEADERSHIP MAPPING
    • 11.4.1 VISIONARY LEADERS
    • 11.4.2 DYNAMIC DIFFERENTIATORS
    • 11.4.3 INNOVATORS
    • 11.4.4 EMERGING COMPANIES
  • 11.5 COMPETITIVE SCENARIO
    • 11.5.1 KEY PRODUCT LAUNCHES
    • 11.5.2 KEY PARTNERSHIPS & COLLABORATIONS
    • 11.5.3 KEY ACQUISITIONS

12 COMPANY PROFILES (Business overview, Products and Services offered, Recent developments, MNM view)*

  • 12.1 THERMO FISHER SCIENTIFIC
  • 12.2 MERCK
  • 12.3 HORIZON DISCOVERY
  • 12.4 GENSCRIPT
  • 12.5 SANGAMO THERAPEUTICS
  • 12.6 LONZA
  • 12.7 EDITAS MEDICINE
  • 12.8 CRISPR THERAPEUTICS
  • 12.9 EUROFINS SCIENTIFIC
  • 12.10 PRECISION BIOSCIENCES
  • 12.11 OXFORD GENETICS
  • 12.12 INTELLIA THERAPEUTICS
  • 12.13 SYNTHEGO
  • 12.14 VIGENE BIOSCIENCES
  • 12.15 EPIGENIE
  • 12.16 INTEGRATED DNA TECHNOLOGIES
  • 12.17 NEW ENGLAND BIOLABS
  • 12.18 ORIGENE TECHNOLOGIES
  • 12.19 TRANSPOSAGEN BIOPHARMACEUTICALS
  • 12.20 CREATIVE BIOGENE

*Business overview, Products and Services offered, Recent developments, MNM view might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.